Cargando…

Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants

BACKGROUND: Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-β (Aβ) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Haitian, Dreses-Werringloer, Ute, Davies, Peter, Marambaud, Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527505/
https://www.ncbi.nlm.nih.gov/pubmed/18710491
http://dx.doi.org/10.1186/1756-0500-1-38
_version_ 1782158810042859520
author Zhao, Haitian
Dreses-Werringloer, Ute
Davies, Peter
Marambaud, Philippe
author_facet Zhao, Haitian
Dreses-Werringloer, Ute
Davies, Peter
Marambaud, Philippe
author_sort Zhao, Haitian
collection PubMed
description BACKGROUND: Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-β (Aβ) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infections, contaminations of cell cultures with mycoplasmas represent a challenging issue in terms of detectability and prevention. Mycoplasmas are the smallest and simplest self-replicating bacteria and the consequences of an infection for the host cells are variable, ranging from no apparent effect to induction of apoptosis. FINDINGS: Here we present evidence that mycoplasmas from a cell culture contamination are able to efficiently and rapidly degrade extracellular Aβ. As a result, we observed no accumulation of Aβ in the conditioned medium of mycoplasma-positive cells stably transfected with the amyloid-β precursor protein (APP). Importantly, eradication of the mycoplasma contaminant – identified as M. hyorhinis – by treatments with a quinolone-based antibiotic, restored extracellular Aβ accumulation in the APP-transfected cells. CONCLUSION: These data show that mycoplasmas degrade Aβ and thus may represent a significant source of variability when comparing extracellular Aβ levels in different cell lines. On the basis of these results, we recommend assessment of mycoplasma contaminations prior to extracellular Aβ level measurements in cultured cells.
format Text
id pubmed-2527505
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25275052008-09-01 Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants Zhao, Haitian Dreses-Werringloer, Ute Davies, Peter Marambaud, Philippe BMC Res Notes Short Report BACKGROUND: Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-β (Aβ) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infections, contaminations of cell cultures with mycoplasmas represent a challenging issue in terms of detectability and prevention. Mycoplasmas are the smallest and simplest self-replicating bacteria and the consequences of an infection for the host cells are variable, ranging from no apparent effect to induction of apoptosis. FINDINGS: Here we present evidence that mycoplasmas from a cell culture contamination are able to efficiently and rapidly degrade extracellular Aβ. As a result, we observed no accumulation of Aβ in the conditioned medium of mycoplasma-positive cells stably transfected with the amyloid-β precursor protein (APP). Importantly, eradication of the mycoplasma contaminant – identified as M. hyorhinis – by treatments with a quinolone-based antibiotic, restored extracellular Aβ accumulation in the APP-transfected cells. CONCLUSION: These data show that mycoplasmas degrade Aβ and thus may represent a significant source of variability when comparing extracellular Aβ levels in different cell lines. On the basis of these results, we recommend assessment of mycoplasma contaminations prior to extracellular Aβ level measurements in cultured cells. BioMed Central 2008-06-30 /pmc/articles/PMC2527505/ /pubmed/18710491 http://dx.doi.org/10.1186/1756-0500-1-38 Text en Copyright © 2008 Zhao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Zhao, Haitian
Dreses-Werringloer, Ute
Davies, Peter
Marambaud, Philippe
Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
title Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
title_full Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
title_fullStr Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
title_full_unstemmed Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
title_short Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
title_sort amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527505/
https://www.ncbi.nlm.nih.gov/pubmed/18710491
http://dx.doi.org/10.1186/1756-0500-1-38
work_keys_str_mv AT zhaohaitian amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants
AT dreseswerringloerute amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants
AT daviespeter amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants
AT marambaudphilippe amyloidbetapeptidedegradationincellculturesbymycoplasmacontaminants